OpenSAFELY Vaccine Coverage Report
Pfizer / Priority Group 2
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 67.4% | 1,724,373 | 2,558,794 | 67.1% | 0.3% |
| Sex | Female | 65.3% | 967,358 | 1,481,886 | 65.0% | 0.3% |
| Male | 70.3% | 757,015 | 1,076,908 | 70.0% | 0.3% | |
| Ethnicity | White - British | 69.7% | 1,002,008 | 1,438,598 | 69.3% | 0.4% |
| White - Irish | 65.8% | 13,741 | 20,895 | 65.4% | 0.4% | |
| White - Any other White background | 59.9% | 32,893 | 54,922 | 59.6% | 0.3% | |
| Mixed - White and Black Caribbean | 42.9% | 1,589 | 3,703 | 42.7% | 0.2% | |
| Mixed - White and Black African | 43.1% | 504 | 1,169 | 43.1% | 0.0% | |
| Mixed - White and Asian | 59.6% | 784 | 1,316 | 59.0% | 0.5% | |
| Mixed - Any other mixed background | 54.6% | 1,281 | 2,345 | 54.6% | 0.0% | |
| Asian or Asian British - Indian | 64.1% | 20,993 | 32,725 | 63.9% | 0.3% | |
| Asian or Asian British - Pakistani | 42.2% | 7,049 | 16,716 | 42.1% | 0.1% | |
| Asian or Asian British - Bangladeshi | 44.3% | 2,163 | 4,879 | 44.0% | 0.3% | |
| Asian or Asian British - Any other Asian background | 55.6% | 6,440 | 11,585 | 55.3% | 0.3% | |
| Black or Black British - Caribbean | 38.4% | 8,974 | 23,359 | 38.3% | 0.1% | |
| Black or Black British - African | 31.5% | 2,716 | 8,624 | 31.4% | 0.1% | |
| Black or Black British - Any other Black background | 39.5% | 987 | 2,499 | 39.5% | 0.0% | |
| Other ethnic groups - Chinese | 52.5% | 2,149 | 4,095 | 52.1% | 0.3% | |
| Other ethnic groups - Any other ethnic group | 47.3% | 3,234 | 6,832 | 46.9% | 0.4% | |
| Patients with any other ethnicity code | 69.1% | 272,951 | 395,017 | 68.9% | 0.2% | |
| Ethnicity not stated | 62.3% | 10,269 | 16,492 | 62.1% | 0.2% | |
| Ethnicity not recorded | 65.0% | 333,529 | 512,925 | 64.8% | 0.2% | |
| Ethnicity (broad categories) | White | 69.2% | 1,048,656 | 1,514,422 | 68.9% | 0.4% |
| Mixed | 48.9% | 4,179 | 8,554 | 48.6% | 0.2% | |
| South Asian | 55.6% | 36,673 | 65,919 | 55.4% | 0.3% | |
| Black | 36.8% | 12,698 | 34,482 | 36.7% | 0.1% | |
| Other | 49.3% | 5,390 | 10,934 | 48.9% | 0.4% | |
| Unknown | 66.7% | 616,770 | 924,455 | 66.5% | 0.2% | |
| Index of Multiple Deprivation | 1 (most deprived) | 59.8% | 203,847 | 340,886 | 59.5% | 0.3% |
| 2 | 64.6% | 279,923 | 433,615 | 64.3% | 0.3% | |
| 3 | 67.7% | 366,541 | 541,702 | 67.4% | 0.3% | |
| 4 | 69.5% | 408,933 | 588,532 | 69.2% | 0.3% | |
| 5 (least deprived) | 71.1% | 451,220 | 634,333 | 70.8% | 0.3% | |
| Unknown | 70.5% | 13,888 | 19,691 | 70.5% | 0.0% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 67.5% | 1,245,944 | 1,845,228 | 67.2% | 0.3% |
| Patients with Immunosuppression | 70.0% | 77,651 | 110,964 | 69.7% | 0.3% | |
| Patients with CKD | 67.1% | 525,336 | 783,069 | 66.8% | 0.3% | |
| Patients who have Chronic Respiratory Disease | 67.8% | 207,921 | 306,740 | 67.5% | 0.3% | |
| Patients with Diabetes | 66.3% | 344,456 | 519,372 | 66.0% | 0.3% | |
| Patients with Chronic Liver disease | 68.0% | 31,780 | 46,753 | 67.7% | 0.3% | |
| Patients with CNS Disease (including Stroke/TIA) | 62.8% | 269,262 | 428,449 | 62.5% | 0.3% | |
| Patients with Chronic heart disease | 67.6% | 732,963 | 1,083,929 | 67.3% | 0.3% | |
| Patients with Asplenia or Dysfunction of the Spleen | 70.7% | 14,560 | 20,601 | 70.4% | 0.3% | |
| Patients with Wider Learning Disability | 43.0% | 560 | 1,302 | 43.0% | 0.0% | |
| Patients with Severe Mental Health | 50.6% | 8,799 | 17,395 | 50.4% | 0.2% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 62.1% | 468,181 | 753,354 | 61.9% | 0.3% |
| Patients with Morbid Obesity | 57.7% | 20,195 | 34,972 | 57.5% | 0.3% | |
| Patients who are pregnant | 68.9% | 217 | 315 | 68.9% | 0.0% |